| Literature DB >> 32863496 |
Adrian Garcia Badaracco1, Erin Ward2, Christopher Barback3, Jian Yang4, James Wang1, Ching-Hsin Huang1, Moon Kim5, Qingxiao Wang5, Seungjin Nam5, Jonathan Delong2, Sarah Blair2, William C Trogler4, Andrew Kummel4.
Abstract
Marking colon tumors for surgery is normally done with the use of India ink. However, non-fluorescent dyes such as India ink cannot be imaged below the tissue surface and there is evidence for physiological complications such as abscess, intestinal perforation and inconsistency of dye injection. A novel infrared marker was developed using FDA approved indocyanine green (ICG) dye and ultrathin hollow silica nanoshells (ICG/HSS). Using a positively charged amine linker, ICG was non-covalently adsorbed onto the nanoparticle surface. For ultra-thin wall 100 nm diameter silica shells, a bimodal ICG layer of < 3 nm is was formed. Conversely, for thicker walls on 2 μm diameter silica shells, the ICG layer was only bound to the outer surface and was 6 nm thick. In vitro testing of fluorescent emission showed the particles with the thinner coating were considerably more efficient, which is consistent with self-quenching reducing emission shown in the thicker ICG coatings. Ex-vivo testing showed that ICG bound to the 100 nm hollow silica shells was visible even under 1.5 cm of tissue. In vivo experiments showed that there was no diffusion of the ICG/nanoparticle marker in tissue and it remained imageable for as long as 12 days.Entities:
Year: 2019 PMID: 32863496 PMCID: PMC7455021 DOI: 10.1016/j.apsusc.2019.143885
Source DB: PubMed Journal: Appl Surf Sci ISSN: 0169-4332 Impact factor: 6.707